Xeris Biopharma Holdings, Inc. XERS Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s common stock?
- Xeris Biopharma Holdings, Inc. (XERS) reported common stock of $18K in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s common stock changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s common stock increased by 12.5% year-over-year, from $16K to $18K.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s common stock?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s common stock has grown at a 23.2% compound annual growth rate (CAGR), from $6K to $17K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).